Clinical Trials Sponsored by Trium Clinical Consulting

Total 90 results

Cochlear
Avania; Trium Clinical Consulting

Completed

Sound Processing. ( A Feasibility, Prospective, Repeated-measures Investigation to Investigate Innovations in Sound Processing in Adult and Paediatric Recipients Implanted With CE Approved Nucleus Cochlear Implants: an Umbrella Investigation)

Hearing Loss

Belgium, Australia
TripleMed B.V.
Trium Clinical Consulting

Recruiting

ANEUFIX for Endoleak Type II Repair

Abdominal Aortic Aneurysm | Endoleak

Belgium, Netherlands
TripleMed B.V.
Trium Clinical Consulting

Suspended

AneuFix - Prophylactic Sac Filling

Abdominal Aortic Aneurysm | Endoleak

Netherlands
Grand Medical Pty Ltd.
Trium Clinical Consulting

Completed

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Severe COVID-19 Pneumonia

Belgium
Klynical Consulting & Services

Completed

Safety Evaluation of SS-POR11

Acne

Canada
Imelda Hospital, Bonheiden
Universitaire Ziekenhuizen KU Leuven; AZ Sint-Jan AV; Biosense Webster, Inc.; Trium...

Recruiting

Efficacy of a Right-sided Ablation of the Anterior Ganglionated Plexus for Neurally Mediated Syncope (CardNMH3)

Syncope | Syncope, Neurogenic

Belgium
Soliton
Emergent Clinical Consulting, LLC

Completed

Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar (ASR)

Keloid Scar

United States
University of Michigan
Twine Clinical Consulting

Completed

Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States
InnoMed Healthscience Inc.
RVW Clinical Consulting

Terminated

Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
InnoMed Healthscience Inc.
RVW Clinical Consulting

Completed

Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
Durect
CTI Clinical Trial and Consulting Services

Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)

Alcoholic Hepatitis

United States, Australia, United Kingdom, France, Belgium, Austria
Durect
CTI Clinical Trial and Consulting Services

Completed

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis (AH)

Alcoholic Hepatitis

United States
University of Michigan
Twine Clinical Consulting LLC

Completed

Care Coordination and Proactive Care to Improve Utilization of Resources and Reduce Expenditure in High Risk Inflammatory Bowel Disease (IBD) Patients (CAPTURE IBD)

Inflammatory Bowel Diseases

United States
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Cytomedix
CTI Clinical Trial and Consulting Services

Terminated

The AutoloGel™ Post-Market Surveillance (TAPS) Program (TAPS)

Diabetic Foot Ulcers | Wounds | Pressure Ulcers | Leg Ulcers

United States
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

Chronic Kidney Disease | Congenital Anomalies of Kidney and Urinary Tract

United States
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Prokidney
CTI Clinical Trial and Consulting Services

Terminated

Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) (RMCL-CL001)

Type 2 Diabetes | Chronic Kidney Disease

United States
Asahi Kasei Pharma Corporation
Emergent Clinical Consulting, LLC

Terminated

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) (ENHANCE)

Spinal Stenosis | Degenerative Spondylolisthesis

Canada
Alexion Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)

Delayed Graft Function

France, Germany, Italy, Spain, United States, Canada, Brazil, Australia, Czechia
MaxCyte, Inc.
CTI Clinical Trial and Consulting Services

Terminated

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Fallopian Tube Adenocarcinoma | Peritoneal Mesothelioma | Primary Peritoneal Carcinoma | Adenocarcinoma of the Ovary

United States
Tufts University
MB Clinical Research and Consulting LLC

Completed

Vitamin and Mineral Supplementation Improves Micronutrient Status in Older Adults

Nutrient Deficiency

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients

Liver Failure

United States
DiscGenics, Inc.
CTI Clinical Trial and Consulting Services

Completed

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Degenerative Disc Disease

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

Renal Failure

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services; Everest Clinical Research; Clinical...

Active, not recruiting

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

Acute Kidney Injury

United States, Georgia, Canada, Brazil
PainChek Ltd
Donawa Lifescience Consulting SRL; TechnoSTAT Clinical Services

Recruiting

PainChek® US Validation Nursing Home Study

Pain | Dementia

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Enrolling by invitation

Continued Treatment for Participants Enrolled in Studies of BXQ-350 (ETERNITI)

Neoplasms

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

COVID-19 | Pneumonia

Brazil
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services; Aptuit

Completed

Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

Liver Failure

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services; Aptuit

Completed

Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

Renal Failure | Kidney Failure

United States
BTG International Inc.
CTI Clinical Trial and Consulting Services

Approved for marketing

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Neoplasms
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Recruiting

BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients (RETRO)

Chemotherapy-induced Peripheral Neuropathy | Neuropathy;Peripheral

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Recruiting

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (KONQUER)

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Completed

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Neoplasms

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Delayed Graft Function

United States
Abderrahmane Mami Hospital
Dacima Consulting; Eshmoun Clinical Research Center

Withdrawn

Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+) (COVID+PA)

Patients With COVID19

Tunisia
Alavita Pharmaceuticals Inc
CTI Clinical Trial and Consulting Services

Completed

Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients

Kidney Transplantation

United States
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Terminated

A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors (KOURAGE)

Neoplasms

United States
CTI-1, LLC
GlaxoSmithKline; CTI Clinical Trial and Consulting Services

Completed

A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure (COMPARE)

Congestive Heart Failure

United States
AZTherapies, Inc.
Pharma Consulting Group AB; KCAS; Panax Clinical Research

Completed

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

Healthy Volunteers

United States
Bexion Pharmaceuticals, Inc.
ICON plc; CTI Clinical Trial and Consulting Services

Recruiting

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma (ASIST)

Neuropathy | Metastatic Colorectal Carcinoma

United States
Biomat USA, Inc.
Axio Research. LLC; Hammond Clinical Trial Consulting, LLC

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy

United States
ImmunoBiology Limited
Simbec Research; ORION Clinical Services; Oxford Therapeutics Consulting Limited

Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax

Pneumococcal Infection

United Kingdom
Silence Therapeutics GmbH
FGK Clinical Research GmbH; Granzer Regulatory Consulting & Services

Completed

Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) (Atu027-I-02)

Carcinoma, Pancreatic Ductal

Germany
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; MedProve Inc; MEDPHASE CLINICAL RESEARCH CONSULTANT... and other collaborators

Active, not recruiting

A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD) (CKD)

Anemia | Chronic Kidney Disease Requiring Chronic Dialysis

Vietnam
CereVasc Inc
AlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...

Terminated

Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus

Hydrocephalus | Hydrocephalus, Communicating

United States
Carl Zeiss Meditec, Inc.
ClinReg Consulting Services, Inc.; Sierra Clinical Services, LLC

Completed

Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam

Cornea

United States
CereVasc Inc
AlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...

Recruiting

Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Hydrocephalus | Hydrocephalus, Normal Pressure

Argentina

Clinical Trials Sponsored by Trium Clinical Consulting

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations